China’s biotechnology sector is entering a new phase of financial maturity as companies move beyond heavy reliance on licensing agreements and tap deeper pools of domestic and international capital. Strong equity market performance, regulatory reforms and expanding innovation pipelines are reshaping the funding
Google has disrupted a Chinese linked cyber espionage operation that compromised at least 53 organizations across 42 countries, according to findings released by the company’s Threat Intelligence Group. The campaign, attributed to a group tracked as UNC2814 and also known as Gallium, is
Chinese smartphone maker Honor is set to enter the humanoid robotics arena with the launch of its first household focused robot, marking a significant expansion beyond its traditional mobile device business. The Shenzhen based company confirmed that the unveiling will take place on
Chinese biotechnology companies are accelerating their push into global markets, with Shanghai based Harbour BioMed announcing a partnership valued at more than US$1.2 billion to advance one of its clinical stage antibody therapies outside mainland China. The agreement underscores a broader shift in
An artificial intelligence summit in New Delhi was overshadowed this week after a private Indian university was asked to remove its exhibition booth over claims surrounding a robotic dog that was later identified as a commercially available Chinese product. The incident unfolded at
China’s industrial landscape is undergoing a structural transformation as robotics adoption accelerates across manufacturing, logistics, and heavy industry. What was once concentrated in automotive assembly lines has expanded into electronics, metals processing, warehousing, and even food production. The scale of deployment reflects more
China’s accelerating biotechnology expansion is driving an unexpected cost surge in one of the industry’s most critical research resources, laboratory monkeys used in preclinical drug testing. Prices for experimental monkeys have climbed to around 140,000 yuan per animal, a level that now exceeds
Chinese robotics companies are experiencing a sharp rise in orders after humanoid machines took center stage during this year’s Spring Festival Gala, one of the country’s most-watched annual broadcasts. The televised event, which draws hundreds of millions of viewers across China and abroad,
China based Unitree Robotics is aiming to scale production of its humanoid robots to as many as 20000 units in 2026, marking a sharp increase from roughly 5500 units shipped in 2025. The ambitious target follows the company’s high visibility appearance at China’s
China’s leading humanoid robotics companies stepped into the national spotlight during this year’s Spring Festival Gala, the annual television spectacle broadcast by state media that reaches hundreds of millions of viewers across the country. Their prominent appearance signalled how robotics is moving from
